Pandemic Resilience: Testing
Event Description
Danielle Allen, Ganesh Sitaraman, and E. Glen Weyl will discuss pandemic resilience and testing in this conversation on the Edmond J. Safra Center for Ethics' COVID-19 white paper series. The discussion will be moderated by Carmel Shachar.
In order to successfully combat the COVID-19 epidemic, we need to thoughtfully mobilize and utilize all resources available. The Edmond J. Safra Center’s COVID-19 Response Initiative, a bipartisan group of experts in economics, public health, technology and ethics from across the country, has released the nation’s first comprehensive operational roadmap for mobilizing and reopening the U.S. economy in the midst of the COVID-19 crisis.
We will explore this operational roadmap to pandemic resilience in a series of events. This event will focus on questions around COVID-19 testing programs. How can states coordinate their public health efforts? How can we reflect the different needs of local communities? What is the role of federal policymakers in creating testing programs and supporting reopening efforts?
Panelists
-
Danielle Allen, James Bryant Conant University Professor at Harvard University, and Director of Harvard’s Edmond J. Safra Center for Ethics.
-
Ganesh Sitaraman, Chancellor's Faculty Fellow, Professor of Law, and Director of the Program on Law and Government at Vanderbilt Law School.
-
E. Glen Weyl, Microsoft's Office of the Chief Technology Officer's Political Economist and Social Technologist, and the Founder and Chair of the RadicalxChange Foundation.
- Moderator: Carmel Shachar, Executive Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and Lecturer on Law, Harvard Law School
Online Viewing
Due to the ongoing closure of Harvard University, this event will be held entirely online. The event is free and open to the public, but registration is required. Registrants will receive the Zoom link and password the day before the event.
Sponsored by the Edmond J. Safra Center for Ethics at Harvard University and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.